Evidence map›Paper›PMID 28315998›Full record

ArticleJournal of neuro-oncology2017

Chordoid glioma of the third ventricle: report of a rapidly progressive case.

Amalie A Erwood, Jose E Velazquez-Vega, Stewart Neill, David A Solomon, Nicholas Butowski, Adam Nowlan, Erin Dunbar, Daniel J Brat

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Benign Glioma.Advances in experimental medicine and biology · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Amalie A ErwoodEmory University School of Medicine, Atlanta, GA, USA.
Jose E Velazquez-VegaDepartments of Pathology and Laboratory Medicine, Emory University Hospital, H-195, 1364 Clifton Rd. NE, Atlanta, GA, 30322, USA.
Stewart NeillDepartments of Pathology and Laboratory Medicine, Emory University Hospital, H-195, 1364 Clifton Rd. NE, Atlanta, GA, 30322, USA.
David A SolomonDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USA.
Nicholas ButowskiDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA.
Adam NowlanPiedmont Brain Tumor Center, Piedmont Healthcare, Atlanta, GA, USA.
Erin DunbarPiedmont Brain Tumor Center, Piedmont Healthcare, Atlanta, GA, USA.
Daniel J BratDepartments of Pathology and Laboratory Medicine, Emory University Hospital, H-195, 1364 Clifton Rd. NE, Atlanta, GA, 30322, USA. dbrat@emory.edu.
Emory University · USEmory University Hospital · USPiedmont HealthCare · USNeurological Surgery · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chordoid gliomas are slowly growing third ventricular tumors that can be challenging to manage clinically. Rapid progression causing death has not been previously reported for this tumor type. We present and discuss a case of chordoid glioma that arose in a 46-year-old female who presented with progressive fatigue, headache, and altered mental status, attributable to severe hydrocephalus caused by a third ventricular mass. She underwent urgent subtotal resection and ventriculo-peritoneal shunt placements. Post-operative MRI noted residual tumor in the anterior resection cavity. An MRI performed 9 weeks later showed substantial progression, with marked tumor enlargement and compression of adjacent hypothalamic structures and the optic chiasm. Despite a course of radiation therapy, the tumor continued to enlarge, and the patient died from tumor progression 7 months after initial presentation. Post-mortem exam demonstrated a mass that expanded the third ventricle and compressed adjacent hypothalamic, thalamic and suprasellar structures. Histologic and immunohistochemical studies confirmed a chordoid glioma and revealed multifocal coagulative necrosis and intravascular thrombosis, which are unusual in this tumor type. Cytogenomic microarray testing revealed numerous DNA copy number abnormalities, many of which had not previously been reported in this tumor. The pathologic and cytogenetic changes may correlate with the aggressive behavior of this chordoid glioma and can be pursued by future investigation of additional cases.

Indexed as

Cerebral Ventricle NeoplasmsDisease ProgressionDNA Copy Number VariationsFatal OutcomeFemaleGliomaHumansMiddle AgedThird VentricleBrain tumorChordoid gliomaCytogeneticsProgression

Identifiers

PMID28315998
OpenAlexW2595261215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.